Active hexose correlated compound enhances tumor surveillance through regulating both innate and adaptive immune responses
Active hexose correlated compound enhances tumor surveillance through regulating both innate and adaptive immune responses
复制标题
DOI:
10.1007/s00262-005-0111-9
复制
发表时间:
2006-10-01
影响因子:
5.8
通讯作者:
Yin, Zhinan
中科院分区:
文献类型:
--
作者:
Gao, Yunfei;Zhang, Dongqing;Yin, Zhinan
Active hexose correlated compound (AHCC) is a mixture of polysaccharides, amino acids, lipids and minerals derived from cocultured mycelia of several species of Basidiomycete mushrooms. AHCC has been implicated to modulate immune functions and plays a protective role against infection. However, the potential role of AHCC in tumor immune surveillance is unknown. In this study, C57BL/6 mice were orally administered AHCC or water, followed by tumor cell inoculation. We showed that compared to pure water-treated mice, AHCC treatment significantly delayed tumor development after inoculation of either melanoma cell line B16F0 or lymphoma cell line EL4. Treatment with AHCC enhanced both Ag-specific activation and proliferation of CD4(+) and CD8(+) T cells, increased the number of tumor Ag-specific CD8(+) T cells, and more importantly, increased the frequency of tumor Ag-specific IFN-gamma producing CD8(+) T cells. Interestingly, AHCC treatment also showed increased cell number of NK and gamma delta T cells, indicating the role of AHCC in activating these innate-like lymphocytes. In summary, our results demonstrate that AHCC can enhance tumor immune surveillance through regulating both innate and adaptive immune responses.